Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Prescriber's Guide_ Stahl's Ess - Stephen M. Stahl.docx
Скачиваний:
1
Добавлен:
01.07.2025
Размер:
3 Мб
Скачать
☆

Elderly

• Baseline ECG is recommended for patients over age 50

• May be more sensitive to anticholinergic, cardiovascular, hypotensive, and sedative effects

• Reduction in the risk of suicidality with antidepressants compared to placebo in adults age 65 and older

Children and Adolescents

• Carefully weigh the risks and benefits of pharmacological treatment against the risks and benefits of nontreatment with antidepressants and make sure to document this in the patient’s chart

• Monitor patients face-to-face regularly, particularly during the first several weeks of treatment

• Use with caution, observing for activation of known or unknown bipolar disorder and/or suicidal ideation, and inform parents or guardians of this risk so they can help observe child or adolescent patients

• Not recommended for use in children under age 18

• Several studies show lack of efficacy of TCAs for depression

• May be used to treat enuresis or hyperactive/impulsive behaviors

• Some cases of sudden death have occurred in children taking TCAs

Pregnancy

• Risk Category C [some animal studies show adverse effects; no controlled studies in humans]

• Crosses the placenta

• Adverse effects have been reported in infants whose mothers took a TCA (lethargy, withdrawal symptoms, fetal malformations)

• Not generally recommended for use during pregnancy, especially during first trimester

• Must weigh the risk of treatment (first trimester fetal development, third trimester newborn delivery) to the child against the risk of no treatment (recurrence of depression, maternal health, infant bonding) to the mother and child

• For many patients this may mean continuing treatment during pregnancy

Breast Feeding

• Some drug is found in mother’s breast milk

✽ Recommended either to discontinue drug or bottle feed

• Immediate postpartum period is a high-risk time for depression, especially in women who have had prior depressive episodes, so drug may need to be reinstituted late in the third trimester or shortly after childbirth to prevent a recurrence during the postpartum period

• Must weigh benefits of breast feeding with risks and benefits of antidepressant treatment versus nontreatment to both the infant and the mother

• For many patients this may mean continuing treatment during breast feeding

DOTHIEPIN: THE ART OF PSYCHOPHARMACOLOGY

Potential Advantages

• Patients with insomnia

• Severe or treatment-resistant depression

• Anxious depression

Potential Disadvantages

• Pediatric and geriatric patients

• Patients concerned with weight gain

• Cardiac patients

Primary Target Symptoms

• Depressed mood

• Chronic pain

Pearls

✽ Close structural similarity to amitriptyline

• Tricyclic antidepressants are often a first-line treatment option for chronic pain

• Tricyclic antidepressants are no longer generally considered a first-line option for depression because of their side effect profile

• Tricyclic antidepressants continue to be useful for severe or treatment-resistant depression

• TCAs may aggravate psychotic symptoms

• Alcohol should be avoided because of additive CNS effects

• Underweight patients may be more susceptible to adverse cardiovascular effects

• Children, patients with inadequate hydration, and patients with cardiac disease may be more susceptible to TCA-induced cardiotoxicity than healthy adults

• For the expert only: a heroic treatment (but potentially dangerous) for severely treatment-resistant patients is to give simultaneously with monoamine oxidase inhibitors for patients who fail to respond to numerous other antidepressants, but generally recommend a different TCA than dothiepin for this use

• If this option is elected, start the MAOI with the tricyclic/tetracyclic antidepressant simultaneously at low doses after appropriate drug washout, then alternately increase doses of these agents every few days to a week as tolerated

• Although very strict dietary and concomitant drug restrictions must be observed to prevent hypertensive crises and serotonin syndrome, the most common side effects of MAOI and tricyclic/tetracyclic antidepressant combinations may be weight gain and orthostatic hypotension

• Patients on TCAs should be aware that they may experience symptoms such as photosensitivity or blue-green urine

• SSRIs may be more effective than TCAs in women, and TCAs may be more effective than SSRIs in men

• Since tricyclic/tetracyclic antidepressants are substrates for CYP450 2D6, and 7% of the population (especially Caucasians) may have a genetic variant leading to reduced activity of 2D6, such patients may not safely tolerate normal doses of tricyclic/tetracyclic antidepressants and may require dose reduction

• Phenotypic testing may be necessary to detect this genetic variant prior to dosing with a tricyclic/tetracyclic antidepressant, especially in vulnerable populations such as children, elderly, cardiac populations, and those on concomitant medications

• Patients who seem to have extraordinarily severe side effects at normal or low doses may have this phenotypic CYP450 2D6 variant and require low doses or switching to another antidepressant not metabolized by 2D6

Suggested Reading

Anderson IM. Meta-analytical studies on new antidepressants. Br Med Bull 2001; 57:161–78.

Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Aff Disorders 2000;58:19–36.

Donovan S, Dearden L, Richardson L. The tolerability of dothiepin: a review of clinical studies between 1963 and 1990 in over 13,000 depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18:1143–62.

Lancaster SG, Gonzalez JP. Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1989;38:123–47.

DOXEPIN

DOXEPIN: THERAPEUTICS

Brands

• Sinequan, Silenor

see index for additional brand names

Generic?

Yes

Class

• Tricyclic antidepressant (TCA)

• Serotonin and norepinephrine/noradrenaline reuptake inhibitor

• Antihistamine

Commonly Prescribed for

(bold for FDA approved)

• Psychoneurotic patient with depression and/or anxiety

• Depression and/or anxiety associated with alcoholism

• Depression and/or anxiety associated with organic disease

• Psychotic depressive disorders with associated anxiety

• Involutional depression

• Manic-depressive disorder

• Insomnia (difficulty with sleep maintenance) (Silenor only)

✽ Pruritus/itching (topical)

• Dermatitis, atopic (topical)

• Lichen simplex chronicus (topical)

• Anxiety

• Neuropathic pain/chronic pain

• Treatment-resistant depression

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]